Click here to create your personal news page. The news that appears on Drug Manufacturers will appear there and be constantly updated. You can then modify the page, share it with your friends, or export it and have it appear elsewhere.

You can also create a personal news page and follow the news that interests you by clicking on the tab labelled 'New page'.
 

topics : related - allExplore

Wikio Shopping

  1. 1. Computers
  2. 2. Electronics
  3. 3. Communication
  4. 4. Household Appliances
  5. 5. Car/Motor Bike
  6. 6. Digital Camera
  7. 7. Mobile Phone
  8. 8. Smartphone
  9. 9. PDA
  10. 10. GPS
  11. 11. LCD Monitor
  12. 12. Printer

New products

  1. 1. PowerColor Radeon HD 4870 1GB
  2. 2. Panasonic Lumix FX150
  3. 3. Panasonic Lumix FZ28
  4. 4. Gigabyte iSolo 3314
  5. 5. Panasonic Lumix LX3
  6. 6. Sapphire Radeon HD 4870 1GB
  7. 7. Shuttle SX48P2 Deluxe
  8. go to Shopping

Participate



Drug Manufacturers


Sort by : relevance - date - popularity
+Vote!

Top drug companies' earnings beat forecasts

LONDON (Reuters) - The world's two biggest drugmakers, Pfizer and GlaxoSmithKline , both beat expectations for quarterly earnings on Wednesday, as did Wyeth , indicating the sector's resilience.

+Vote!

Drug Company Profits Continue to Soar

Washington's largest lobby, the pharmaceutical industry, had a very successful year backed by a record $168 million lobbying effort. Among the industry's successes were getting two controversial laws extended, and thwarting congressional efforts to restrict media ads for prescription drugs. The spending represents a 32 percent jump over 2006 numbers, driven in part by a busy legislative calendar dominated...

+Vote!

Top drug companies' earnings beat forecasts

LONDON (Reuters) - The world's two biggest drugmakers, Pfizer Inc and GlaxoSmithKline Plc , both beat expectations for quarterly earnings on Wednesday, as did Wyeth , indicating the sector's resilience.

+Vote!

Top drug companies' earnings beat forecasts

LONDON (Reuters) - The world's two biggest drugmakers, Pfizer Inc and GlaxoSmithKline Plc , both beat expectations for quarterly earnings on Wednesday, as did Wyeth , indicating the sector's resilience.

+Vote!

Drug Firm’s Profit Surpasses Estimates

Biogen Idec reported a higher-than-expected second-quarter profit on Tuesday as sales of its closely watched multiple sclerosis drug Tysabri surged past Wall Street estimates.

+Vote!

State to get nearly $7 million in settlement with drug company

Bristol-Myers Squibb has agreed to pay the Washington state nearly $7 million to settle allegations of illegal marketing and pricing of prescription medications.

+Vote!
+Vote!

Glaxo set for big push into emerging markets

GlaxoSmithKline's new chief executive signalled his intent to launch an expansion drive into the emerging markets yesterday as he revealed his strategic objectives for the first time and announced a "transformational" partnership with a South African drugs company.

+Vote!
+Vote!

Witty's blueprint for a new GSK

GLAXOSMITHKLINE must change to survive the growing threat of generic competition for its leading products, its chief executive warned yesterday.

+Vote!

Pfizer earnings boosted by prescription drugs sales and cost-cutting

Pfizer yesterday reported that its second quarter earnings had more than doubled on higher sales of its prescription drugs and with lower expenses. In a conference...

+Vote!

Glaxo earnings fall 3% to £1.29bn

GlaxoSmithkline, the world’s second-largest drug maker, posted a 3% fall in second-quarter net profit yesterday after strong competition from generic drugs outweighed asset sales and the cost-saving effects of job cuts.

+Vote!

Glaxo Battles Slow Growth

GlaxoSmithKline will make additional changes to its drug-research team and work with a company that sells low-cost medicines in emerging markets. The U.K. drug giant posted weak second-quarter results.

+Vote!

Keeping in step with focus on off-patent medicines

GlaxoSmithKline's shift into generic drugs by means of its partnership with Aspen reflects and develops a trend during recent years by large pharmaceutical companies...

+Vote!

Glaxo takes big Strides in generics

Mumbai, July 23: GlaxoSmithKline has entered into an alliance with Onco Therapies Ltd, a joint venture of Strides Arcolab, in branded generics.